December 18, 2017
Teva swings huge axe, suspends dividend, no bonuses. Tough year for Israeli drugmaker
According to the press release from Thursday, Teva said it needs to reduce total cost base by $3 billion by the end…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: patents
January 31, 2017
US Court rules in Mylan’s favor, another decision against Teva
Israel’s largest drugmaker, Teva, has came up short yet again against a US courts regarding patent infringement cases.